SEATTLE (WLNS) – A clinical trial of an investigational vaccine to protect against COVID-19 has begun in Seattle.
The trial at Kaiser Permanente Washington Health Research Institute will enroll 45 healthy volunteers ages 18 to 55 years over approximately 6 weeks.
“Finding a safe and effective vaccine to prevent infection with SARS-CoV-2 is an urgent public health priority,” said National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, M.D. “This Phase 1 study, launched in record speed, is an important first step toward achieving that goal.”
The vaccine is called mRNA-1273 and was developed by NIAID scientists as well as a biotechnology company based in Cambridge, Massachusetts.
The study uses different doses of the experimental vaccine for safety and effectiveness in participants. This is the first of multiple steps in the clinical trial process for determining the potential benefit of the vaccine.
The mRNA-1273 vaccine has “shown promise” in animal models, and this is the first trial to examine it in humans, according to the National Institutes of Health.
Scientists were able to quickly develop mRNA-1273 because of prior studies of related coronaviruses that cause severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS).
Currently, no approved vaccines exist to prevent infection with SARS-CoV-2.
“This work is critical to national efforts to respond to the threat of this emerging virus,” Dr. Jackson said.
As of March 15, 2020, the World Health Organization has reported 153,517 cases of COVID-19 and 5,735 deaths worldwide.
More than 2,800 confirmed COVID-19 cases and 58 deaths have been reported in the United States as of March 15, according to the Centers for Disease Control and Prevention.
Infection with SARS-CoV-2, the virus that causes COVID-19, can cause a mild to severe respiratory illness and include symptoms of fever, cough, and shortness of breath.
- Coronavirus Timeline: Total COVID-19 cases near 175K, deaths now stand at 2,097 in the state
- CHART: Tennessee Department of Health’s count of coronavirus cases by day in state
- Greene County mayor extends mask mandate through September 30
- Video and pictures of packed house party near KU campus spark concern as virus cases rise
- Tennessee Coronavirus: Two weeks into September, state has seen a 12.48% increase in COVID-19 cases and a 19.56% increase in deaths
- Coronavirus in Tennessee: Knox County reports smallest 1-day increase in new cases so far in September
- Oxford and AstraZeneca resume coronavirus vaccine trial
- Tennessee Coronavirus: Total COVID-19 cases reach 171,824 with 933 new cases reported Sunday
- Coronavirus in Tennessee: Inactive cases rise by 204 as Knox County reports 121 new cases & no new deaths
- As Trump played down virus, health experts’ alarm grew
- Dakotas lead US in virus growth as both reject mask rules
- Tennessee Coronavirus: COVID-19 deaths hit 2,064 with 39 new ones reported Saturday
- Coronavirus in Tennessee: Inactive cases rise by 229 as Knox County reports 189 new cases & 3 new deaths
- As restaurants, bars re-open amid coronavirus, CDC study urges caution
- Ohio college students test positive for coronavirus, throw party